echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > New developments in drug launches in Europe and the United States Fosun, Changzhou, Ambition...

    New developments in drug launches in Europe and the United States Fosun, Changzhou, Ambition...

    • Last Update: 2019-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In October, 8 kinds of drugs in domestic pharmaceutical enterprises were approved by FDA for listing There are three orphan drugs approved by FDA in October In October, 34 kinds of human drugs were approved for marketing in HMA of EU In October, there were 8 drugs approved by the FDA (food and Drug Administration of the United States) for listing by domestic pharmaceutical enterprises (2 are temporarily approved by the FDA, as shown in the application No of the winning bid red) See the table below for details, with a month on month increase of 33%, among which 2 are temporarily approved by Fosun Pharmaceutical According to the notice on the official website: This report lists the original and supplementary approvals of NDAs, andas and Blas * within the specified month, including provisional and original approvals, which may be carried out after the selected month As a result, there may be a difference in the number of queries through the database later Figure 1: distribution of FDA approved drug companies in October Dexamethasone, like other glucocorticoids, has anti-inflammatory, anti endotoxin, immunosuppressive, anti shock and stress enhancing pharmacological effects, so it is widely used in various departments to treat various diseases, such as autoimmune diseases, allergies, inflammation, asthma, dermatology and ophthalmology Dexamethasone sodium phosphate injection is an indispensable first-aid drug for rescuing critically ill patients In the past decade, clinicians have used dexamethasone sodium phosphate to treat and prevent drug allergy caused by various Chinese and Western medicines and fever caused by viral cold, which has increased the clinical dosage of dexamethasone year by year So far, China has become the largest dexamethasone market in the world Scenesses is a synthetic peptide and alpha melanocyte stimulating hormone analogue used in the United States to protect people with erythroprotoporphyria from sun skin damage since October 2019 Scenesses was administered as a subcutaneous implant for two months In October, 34 drugs were approved for marketing in the European Union through HMA decentralization and mutual recognition, which are mainly distributed in colon cancer, gastric cancer, allergic rhinitis, urticaria, weight-loss drugs and insulin secretion promoting agents See the table below for details Note: This report only lists some contents Orlistat is a drug used to treat obesity Its main function is to prevent the absorption of fat in human diet by acting as lipase inhibitor, so as to reduce the intake of calories It is intended to be used together with the low calorie diet directed by the health care provider Orlistat is a saturated derivative of lipstatin, an effective natural inhibitor of pancreatic lipase from isolated bacteria (Streptomyces) Therefore, due to its relative simplicity and stability, Oku Leeji was chosen as an anti obesity drug rather than lipostatin Summary data from clinical trials showed that, in addition to lifestyle changes such as diet and exercise, people taking orlistat lost about 2-3 kg (4.4-6.6 lb) compared to those who did not take the drug in a year Orlistat can also moderately reduce blood pressure and prevent the onset of type 2 diabetes, whether it is weight loss or other effects It can reduce the incidence of type II diabetes in obese people with the same lifestyle changes.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.